Publication | Open Access
FIRST ANALYSIS OF HOVON-65/GMMG-HD4 RANDOMIZED PHASE III TRIAL COMPARING BORTEZOMIB, ADRIAMYCINE, DEXAMETHASONE (PAD) VS VAD AS INDUCTION TREATMENT PRIOR TO HIGH DOSE MELPHALAN (HDM) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)
15
Citations
0
References
2009
Year
Hematological MalignancyFirst AnalysisMedicineHematologyClinical TrialsMyeloid NeoplasiaMultiple MyelomaPharmacotherapyHigh Dose MelphalanOncologyRadiation OncologyHealth Sciences
No additional data available for this publication yet. Check back later!